There are 2867 resources available
Welcome and Introductions
Presenter: Virginie Westeel
Session: Bristol Myers Squibb - The Treatment Paradigm Shift: Unlocking New Chapters with I-O in Thoracic Cancers
Resources:
Webcast
How can patients get involved in clinical trials?
Presenter: Ellen Verschuur-van der Voort
Session: Patient involvement in clinical research: Placing the patient at the centre
Resources:
Slides
Webcast
State of the art: What are the most current data and updates to treatment guidelines for first-line maintenance in ovarian cancer
Presenter: Domenica Lorusso
Session: GSK - Avant-garde: Reframing the art of first-line maintenance therapy to optimise long-term outcomes in advanced ovarian cancer
Resources:
Webcast
Updates in precision approaches to the molecular diagnosis of NSCLC
Presenter: Paul Hofman
Session: Janssen-Cilag International NV - Precision approaches in EGFR-mutant NSCLC: Optimising outcomes for patients
Resources:
Webcast
Tumour-agnostic precision therapeutics in molecular oncology: Target versus tissue context: Evidence for benefit and taxonomy considerations
Presenter: Vivek Subbiah
Session: ESMO Colloquium Supported by Lilly and Thermo Fisher Scientific: The practice and promise of NGS tissue testing for tumour-agnostic precision therapeutics
Resources:
Webcast
Multidisciplinary Conversation: Putting I-O on the Table for Patients with Resectable NSCLC
Presenter: Jonathan Spicer
Session: Bristol Myers Squibb - The Treatment Paradigm Shift: Unlocking New Chapters with I-O in Thoracic Cancers
Resources:
Webcast
How is patient data crucial to advance scientific research?
Presenter: Tom Willgoss
Session: Patient involvement in clinical research: Placing the patient at the centre
Resources:
Slides
Webcast
The art of treatment selection: Importance and impact of early treatment planning
Presenter: Charlie Gourley
Session: GSK - Avant-garde: Reframing the art of first-line maintenance therapy to optimise long-term outcomes in advanced ovarian cancer
Resources:
Webcast
Discussion: How can we address diagnostic challenges of NSCLC in clinical practice?
Presenter: Paul Hofman
Session: Janssen-Cilag International NV - Precision approaches in EGFR-mutant NSCLC: Optimising outcomes for patients
Resources:
Webcast
NGS tissue testing in the search of actionable biomarkers in solid tumours: When is it indicated?
Presenter: Christoph Benedikt Westphalen
Session: ESMO Colloquium Supported by Lilly and Thermo Fisher Scientific: The practice and promise of NGS tissue testing for tumour-agnostic precision therapeutics
Resources:
Webcast